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SUMMARY
Previous evidence has suggested that Northern Ireland is a low seroprevalence area for HIV
infection. TheUnlinkedAnonymousHIVPrevalenceMonitoringProgrammeinitiatedinEngland
andWalesin 1990wasextendedtoNorthernIrelandin1992.PatientsattendingtheGenitourinary
Medicine Clinic at the Royal Victoria Hospital have, with informed consent, been tested
anonymously for HIV infection since that time. The results ofthe survey between 1992 and 1995
have shown an overall seroprevalence rate of 3.01% for homosexual/bisexual men, 0.08% for
heterosexual men, and 0.05% for heterosexual women. These results confirm the previous
impression oflow HIV seroprevalence in Northern Ireland and the survey provides an excellent
longitudinal study by which changes may be monitored.
INTRODUCTION
The Unlinked Anonymous HIV Prevalence
Monitoring Programme was introduced in
Northern Ireland in 1992 in the Department of
Genitourinary medicine (GUM) in the Royal
Victoria Hospital, Belfast, under the auspices of
the Public Health Laboratory Service, having
been initiated in England and Wales in 1990.1
All data available prior to the introduction ofthe
survey suggested a low HIV seroprevalence in
Northern Ireland. Between January 1985 and
December 1991 there was a total of 91 first ever
UK'notifications ofHIVinfectionsfromNorthern
Ireland. The Northern Ireland BloodTransfusion
Service which tests approximately 15,000 new
donors annually forHIV infection identified four
donors as HIV positive during this time. A study
doneintheGUM in 1989testing 500consecutive
newattendersforHIVyieldednopositiveresults.2
In 1991 the Northern Ireland Regional Virus
Laboratory tested 3,003 samples from sources
other than GUM of which three were positive -
all of whom had a clinical diagnosis of HIV
infection at the time oftesting. In 1991 11 out of
1,006 attenders atthe GUM clinic tested positive
for HIV.3 Our concern with these surveys was
that there was the possibility of self-exclusion
fromtestingbythoseathighriskofHIVinfection.
The aims of the Programme nationwide are to
ascertain the seroprevalence and to monitor the
spread of HIV in sentinel groups of patients
attending GUM Clinics, injecting-drug users
attending specialist treatment and support
agencies, and pregnant women proceeding to
birth or having terminations.
Providing estimates of the prevalence of HIV
infected people in these groups assists in
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TABLE
Anonymous HIV Test Results ofpatients attending the Genitourinary Medicine Clinic,
Royal Victoria Hospital Belfast 1992-95.
Sex Sexual Year Objections HIV Positive Total Tested Prevalence
Orientation (%)
M Homo/ 1992 0 3 147 2.04
Bisexual 1993 1 3 116 2.59
1994 1 6 142 4.23
1995 1 4 126 3.17
TOTAL 3 16 531 3.01
M Heterosexual 1992 4 2 2047 0.10
1993 4 0 1930 0.00
1994 2 4 1911 0.21
1995 6 0 1781 0.00
TOTAL 16 6 7669 0.08
F Heterosexual 1992 4 1 1567 0.06
1993 5 2 1561 0.13
1994 13 0 1536 0.00
1995 10 0 1556 0.00
TOTAL 32 3 6220 0.05
predicting the futurenumbers ofpeople withHIV
disease, enabling appropriate service planning.
The Programme comprises six longitudinal
surveys ofsixcategories ofpersons -homosexual
men, bisexual men, heterosexual men and
heterosexual women attenders at GUM clinics,
injecting drug users and pregnant women. In
Northern Ireland only GUM clinic attenders in
the first four categories have been studied.
METHODS
All patients attending theGUM Departmentfrom
Ist January 1992 were given written information
ontheUnlinkedAnonymousHIV Seroprevalence
Monitoring Programme. Verbal consent for
participation was obtained by the examining
doctor.
Individuals eligible forinclusion were those who
were having serum taken for a syphilis serology
testand not surveyedpreviously inthatquarterof
the year.They were also eligible for retesting in
subsequent quarters. Demographic data on age
group, gender and country of birth and
epidemiological data on sexual orientation, past
use of injecting drugs, known diagnosis of HIV
infection and presence of acute or non-acute
sexuallytransmitteddiseases (STD)wasrecorded
in the information sheet attached to the patient's
chart. Data were also collected from persons not
consenting to testing of their blood for HIV
antibodies to ascertain any demographic or
epidemiological trends by which self-excluders
might bias survey results.
The data sheet was removed from the patient's
chart and sent to the Public Health Laboratory
Service to be matched with the HIV test results.
The information could not be linked to patient
identity thus ensuring anonymity.
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RESULTS
There was a total of531 samples tested from the
homosexual/bisexual male group between 1992
and 1995. Sixteen were positive for HIV, giving
anoverallprevalence rateof3.09% (Table). Only
two HIV infected men were aware of their
diagnosis at the time of testing. Of the 16, five
presentedwithanacuteSTDatthetimeoftesting.
Those homosexual/bisexual men testing positive
forHIV were in the 25-45 age bracket except one
who was in the 20-24 age group.
A total of 7,669 samples was tested from the
heterosexual male group. Six were positive for
HIV (2 in 1992, 0 in 1993 and 4 in 1994) giving
a prevalence rate of 0.08%. (Table). Only two
HIV infected men were aware oftheir diagnosis
atthe time oftesting. Ofthese six, fourpresented
with an acute STD.
There was a total of 6,220 samples from
heterosexual women taken between 1992-95.
ThreetestedpositiveforHIV, givingan infection
rate of 0.05% (Table). Of these three, none was
aware ofher HIV status. None presented with an
acute STD.
CONCLUSIONS
Seroprevalence reporting of the data collected
from GUM Departments in England and Wales
has been on a geographical basis. These have
beenattenders atCentralLondonClinics, Greater
London and the South East, and other regions
inclusive of England, Wales, and Northern
Ireland. The Northern Ireland figures have to
date not been identified separately in published
reports. It is interesting to compare the
seroprevalence in Northern Ireland with these
other areas. The prevalence in London clinics
involved in the survey between 1992 and 1995
was 15.1% in homosexual and bisexual males
(with arange in clinic prevalences from 23.1% to
5.9%), 1.0% for heterosexual males, and 0.6% in
heterosexualfemales. IntheareasoutsideLondon
and S.E. England, a prevalence of 4.0% was
detectedinhomosexualandbisexualmales, 0.1%
in heterosexual males, and 0.1% in heterosexual
females. In all areas the group with the highest
prevalence is the homosexual/bisexual male
group.4 Northern Ireland is seen to have a very
much lower prevalence of HIV than the London
and S.E. England regions but the overall figures
for the areas outside London and S.E. England
are not substantially different.
Attenders ataGUM Clinic are likely tobe among
those at greatest risk of HIV infection in our
community. If there were a significant or
increasingprevalenceofundetectedHIVinfection
in our population this would be one of the first
places where this would be detected.
Previous information on seroprevalence could
have been biased by persons not wishing to be
identified as HIV positive excluding themselves
from testing. By ensuring anonymity in the
UnlinkedAnonymous ScreeningProgramme few
persons have self-excluded themselves from
testing. This has enabled us to be confident that
GUM clinic attenders provide a good sentinel
population for HIV seroprevalence in Northern
Ireland.
Theinformationobtainedconfirmsourimpression
that Northern Ireland is a low seroprevalence
area, although not so different from areas outside
London and the South East ofEngland. This may
be due to several factors including cultural
hostilitytoexpressionofhomosexuality, resulting
in homosexual men going to more cosmopolitan
cities such as London or Dublin, the presence of
a small injecting drug community and a small
commercial sex industry. Church influence and
the relatively intact family structure along with
geographic isolation and civil disorder may also
be strong contributory factors.5 As elsewhere in
the UK, homosexual/bisexual men are found to
bethepopulationwiththehighestseroprevalence.
It is a matter ofconcern that few ofthose testing
positive for HIV were aware oftheir HIV status.
It is also alarming that a high proportion ofthose
infected with HIV continue to present with acute
STDs thus indicating the absence of "safe sex"
practices and illustrating the potential for HIV
transmission to people unaware of their HIV
status. Large numbers of homosexual/ bisexual
men, heterosexual men and heterosexual women
continue to acquire new episodes of STDs,6 and
risk of acquiring another STD is a powerful
predictor for HIV infection.7 This indicates the
need for continued targeting of all groups but
perhaps especially homosexual/bisexual men for
preventative intervention.
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